Lumida
/RIGL
⌘K
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc

RIGL
$47.24USD-0.08%-0.04 today

MARKET CAP

882.4M

P/E (TTM)

12.0x

FWD P/E

15.3x

DAY RANGE

$47 – $48

52W RANGE

$25
$52

AI Summary

Stalk
StalkMedium

Despite the medium- and long-term bullish structure under a Stage 2 advance, extreme overbought conditions and an active Bullish Exhaustion pattern signal waning upside follow-through; deferred execution is advised, waiting for a pullback into the rising EMA support zone.

  • Q2 2026 net product sales $67M (+14% YoY)
  • Total Q2 revenues $78.7M; 2026 guidance $275–$290M
  • Intense oncology competition may limit market share gains
Full analysis →
Insider Trades23 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 1, 2026SellRIGLLisa RojkjaerEVP, Chief Medical Officer850$29.86$882.4M-9.57%+89.34%$25.4K-2.44%Stalk
Jun 1, 2026SellRIGLDavid A SantosEVP, Chief Commercial Officer874$29.86$882.4M-9.57%+89.34%$26.1K-1.39%Stalk
Jun 1, 2026SellRIGLRaymond J. FureyEVP, GC, CCO & Corp Sec877$29.86$882.4M-9.57%+89.34%$26.2K-1.69%Stalk
Jun 1, 2026SellRIGLRaul R RodriguezCEO, President2,424$29.86$882.4M-9.57%+89.34%$72.4K-0.86%Stalk
Jun 1, 2026BuyRIGLDean L SchornoEVP & Chief Financial Officer4,309$18.07$882.4M-9.57%+89.34%$77.8K+0.96%Stalk
Feb 10, 2026SellRIGLDavid A SantosEVP, Chief Commercial Officer3,546$34.62$882.4M-9.57%+89.34%$122.8K-7.55%Stalk
Feb 10, 2026SellRIGLRaymond J. FureyEVP, GC, CCO & Corp Sec3,546$34.62$882.4M-9.57%+89.34%$122.8K-9.89%Stalk
Feb 10, 2026SellRIGLDean L SchornoEVP & Chief Financial Officer3,546$34.62$882.4M-9.57%+89.34%$122.8K-5.99%Stalk
Feb 10, 2026SellRIGLLisa RojkjaerEVP, Chief Medical Officer3,758$34.62$882.4M-9.57%+89.34%$130.1K-19.06%Stalk
Feb 10, 2026SellRIGLRaul R RodriguezCEO, President7,607$34.62$882.4M-9.57%+89.34%$263.4K-3.23%Stalk
Feb 2, 2026SellRIGLRaymond J. FureyEVP, GC, CCO & Corp Sec3,968$36.01$882.4M-9.57%+89.34%$142.9K-9.96%Stalk
Feb 2, 2026SellRIGLDean L SchornoEVP & Chief Financial Officer5,488$36.01$882.4M-9.57%+89.34%$197.6K-8.48%Stalk
Feb 2, 2026SellRIGLDavid A SantosEVP, Chief Commercial Officer5,718$36.01$882.4M-9.57%+89.34%$205.9K-10.85%Stalk
Jan 26, 2026SellRIGLRaul R RodriguezCEO, President164,745$32.25$882.4M-9.57%+89.34%$5.3M-0.36%Stalk
Dec 22, 2025BuyRIGLDean L SchornoEVP & Chief Financial Officer6,500$21.51$882.4M-9.57%+89.34%$139.8K+2.92%Stalk
Feb 4, 2025SellRIGLRaymond J. FureyEVP, GC, CCO & Corp Sec2,787$21.40$882.4M-9.57%+89.34%$59.7K-3.41%Stalk
Feb 4, 2025SellRIGLDean L SchornoEVP & Chief Financial Officer3,770$21.38$882.4M-9.57%+89.34%$80.6K-3.14%Stalk
Feb 4, 2025SellRIGLDavid A SantosEVP, Chief Commercial Officer3,921$21.38$882.4M-9.57%+89.34%$83.8K-3.59%Stalk
Feb 4, 2025SellRIGLRaul R RodriguezCEO, President9,352$21.39$882.4M-9.57%+89.34%$200.1K-1.90%Stalk
Jan 24, 2025BuyRIGLRaul R RodriguezCEO, President178,156$21.78$882.4M-9.57%+89.34%$3.9M+0.20%Stalk
Feb 2, 2024SellRIGLDean L SchornoEVP & Chief Financial Officer12,628$1.14$882.4M-9.57%+89.34%$14.3K-1.53%Stalk
Feb 2, 2024SellRIGLDavid A SantosEVP, Chief Commercial Officer14,519$1.14$882.4M-9.57%+89.34%$16.5K-2.01%Stalk
Feb 2, 2024SellRIGLRaul R RodriguezCEO, President52,894$1.14$882.4M-9.57%+89.34%$60.1K-1.27%Stalk